fbpx
Medical Innovation Exchange

Merck to pay up to $1.4B in cancer deal with Kelun, but details are scarce

https://www.fiercebiotech.com/deals/merck-pay-14b-cancer-target-chinese-based-kelun-details-are-elusive

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.